In this episode of AVAC’s Px Pulse podcast series, Carl Dieffenbach, Director of NIH’s Division of AIDS, tells AVAC where he sees the most promise in the field of HIV prevention and what it will take to “put out the fire.”
Golden Age or Fools Gold?
PrEP and Trial Design — A no brainer for some
In this episode of AVAC’s Px Pulse podcast series, Slim Abdool Karim, co-principal investigator of the landmark CAPRISA 004 study, talks about why designing trials with oral PrEP is a must—scientifically and ethically.
Testing Long-Acting PrEP, Easier Said Than Done
In this episode of AVAC’s Px Pulse podcast series, leading researcher Dr. Deborah Donnell tells us why the HIV Prevention Trials Network (HPTN) changed the design of one of two trials testing long-acting cabotegravir, as an injectable PrEP.